secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001213900-26-002359
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals provides investor presentation via RedChip webinar; no specific details disclosed
--------------------------------------------------------------------------------

- Company made investor presentation available on January 8, 2026, in connection with RedChip webinar.
- Presentation covers updated clinical development timelines and regulatory strategy (no details disclosed).
- Filing includes standard forward-looking statement disclaimer; no financial guidance provided.
- Presentation exhibit (Ex. 99.1) contains only cover page and disclaimer, not slide content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/0001213900-26-002359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/ea0272213-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-002359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer